WHO Calls for Stronger Safety Monitoring as GLP-1 Use Expands
Episode Summary
WHO urges stronger safety monitoring as GLP-1 use expands for weight loss, emphasizing appropriate prescribing, product verification, structured follow-up, and adverse-event reporting.